Summary & Overview
HCPCS A4210: Needle-Free Injection Device, Single
HCPCS Level II code A4210 designates a single needle-free injection device, a durable medical supply used to deliver medication without a hypodermic needle. Nationally, the code matters as needle-free delivery technologies can affect care pathways, device-driven supply billing, and payer coverage policies for injectable therapies. Adoption of needle-free devices can influence patient safety, adherence, and pharmacy/device reimbursement flows.
Key payers referenced in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of what A4210 represents, payer coverage considerations, and common billing practices tied to device supply lines. The publication summarizes typical sites of service and the clinical context for device use, and highlights where benchmark and policy updates would be relevant for billing and prior authorization workflows.
This summary is intended to orient billing managers, compliance officers, and clinicians on the clinical meaning and billing context of HCPCS Level II code A4210, and to indicate where organizations should look for payer-specific coverage rules and reimbursement benchmarks. Data not available in the input for detailed benchmarks or payer-specific rates.
Billing Code Overview
HCPCS Level II code A4210 describes a needle-free injection device, each. This item is classified as a durable medical device used to deliver medication without a hypodermic needle. The service type is supply of a single needle-free injection device for medication administration. The typical site of service is outpatient or ambulatory settings where patients receive injections or device-based administration of therapy, including physician offices, clinics, infusion centers, and home health settings.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient scenario involves an adult with diabetes requiring subcutaneous medication administration who is prescribed a needle-free injection device (A4210) to deliver insulin or other subcutaneous therapies without the use of a conventional needle. The device is provided during an outpatient clinic visit, durable medical equipment distribution, or pharmacy pick-up. Clinical workflow: the prescribing clinician documents the medical necessity in the chart (diagnosis, reason for needle-free delivery, and expected benefit), sends a prescription to durable medical equipment (DME) supplier or pharmacy, the supplier verifies coverage and obtains prior authorization if required, dispenses the device, and provides patient education on device operation and safe disposal of associated consumables. Follow-up occurs in subsequent primary care or endocrinology visits to assess glycemic control, device use adherence, and any device-related skin reactions or delivery failures.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
52 | Reduced services | Use when a device or service is partially furnished or only a portion of the device package is supplied. |
53 |